• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Koru Medical Systems Inc (NQ: KRMD )

    2.520 -0.010 (-0.40%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 20,454
    Open 2.510
    Bid (Size) 2.400 (100)
    Ask (Size) 2.780 (1)
    Prev. Close 2.530
    Today's Range 2.490 - 2.530
    52wk Range 1.978 - 3.120
    Shares Outstanding 45,764,225
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024
    From KORU Medical Systems
    Via Business Wire
    KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan
    From KORU Medical Systems, Inc.
    Via Business Wire

    Performance

    YTD
    +5.88%
    +5.88%
    1 Month
    +7.23%
    +7.23%
    3 Month
    +21.15%
    +21.15%
    6 Month
    +21.74%
    +21.74%
    1 Year
    -14.29%
    -14.29%

    More News

    Read More
    Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion
    From KORU Medical Systems
    Via Business Wire
    Recap: KORU Medical Systems Q4 Earnings
    Via Benzinga
    Earnings Outlook For KORU Medical Systems
    Via Benzinga
    KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic
    From KORU Medical Systems, Inc.
    Via Business Wire
    KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic
    From KORU Medical Systems, Inc.
    Via Business Wire
    KRMD Stock Earnings: KORU Medical Systems Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth
    From KORU Medical Systems, Inc.
    Via Business Wire
    KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
    From KORU Medical Systems
    Via Business Wire
    KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
    From KORU Medical Systems, Inc.
    Via Business Wire
    The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness
    Via InvestorPlace
    KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference
    From KORU Medical Systems, Inc.
    Via Business Wire
    KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance
    From KORU Medical Systems, Inc.
    Via Business Wire
    Earnings Scheduled For March 13, 2024
    Via Benzinga
    KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic
    From KORU Medical Systems, Inc.
    Via Business Wire
    KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin
    From KORU Medical Systems, Inc.
    Via Business Wire
    KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
    From KORU Medical Systems
    Via Business Wire
    KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference
    From KORU Medical Systems
    Via Business Wire
    KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023
    From KORU Medical Systems, Inc.
    Via Business Wire
    KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System
    From KORU Medical Systems, Inc.
    Via Business Wire
    KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer
    From KORU Medical Systems, Inc.
    Via Business Wire
    KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook
    From KORU Medical Systems, Inc.
    Via Business Wire
    KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled Syringes
    From KORU Medical Systems, Inc.
    Via Business Wire
    KORU Medical Systems to Participate in Upcoming Investor Conferences
    From KORU Medical Systems
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.